Revenue Showdown: Biogen Inc. vs Bio-Techne Corporation

Revenue Showdown: Biogen Inc. vs Bio-Techne Corporation

In the competitive landscape of biotechnology, Biogen Inc. and Bio-Techne Corporation have been key players. Over the past decade, Biogen has consistently outperformed Bio-Techne in terms of revenue, with Biogen's earnings peaking in 2019 at approximately 14.4 billion USD, nearly 20 times that of Bio-Techne's revenue in the same year. However, Bio-Techne has shown impressive growth, with its revenue increasing by over 220% from 2014 to 2023. This growth trajectory highlights Bio-Techne's strategic advancements in the biotech sector. Meanwhile, Biogen's revenue has seen a decline since 2019, dropping by about 32% by 2023. The data for 2024 is incomplete, but Bio-Techne's upward trend suggests a promising future. This revenue showdown underscores the dynamic nature of the biotech industry, where innovation and strategic positioning are key to sustained growth.